<html>
<head>PUBMED IDs for CBF-A</head>
<body bgcolor='#C5F0F2'><h1>CBF-A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/1398104/'>A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressor.</a> October 1  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/7814413/'>Studies on transcription activation by the multimeric CCAAT-binding factor CBF.</a> January 6  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8662945/'>The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit.</a> June 14  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8921405/'>Chromosomal assignment and tissue expression of CBF-C/NFY-C, the third subunit of the mammalian CCAAT-binding factor.</a> October 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9388234/'>Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y).</a> January 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9612081/'>Role of the CCAAT-binding protein CBF/NF-Y in transcription.</a> June 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9612071/'>[Molecular biology of human caliciviruses, uncultivatable gastroenteritis virus].</a> June 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9612070/'>[Molecular pathology and DNA diagnosis of phenylketonuria and hypermethioninemia].</a> June 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9612067/'>[Role of virus specific protease on virion morphogenesis].</a> June 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11000268/'>CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter.</a> September 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11432731/'>S1 proteins C2 and D2 are novel hnRNPs similar to the transcriptional repressor, CArG box motif-binding factor A.</a> July 4  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12086581/'>Identification of a novel AU-rich-element-binding protein which is related to AUF1.</a> June 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12427543/'>Characterization of the rat RALDH1 promoter. A functional CCAAT and octamer motif are critical for basal promoter activity.</a> November 13  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15068897/'>Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia.</a> April 8  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316020/'>The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-alpha3(V) collagen gene (COL5A3).</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15342744/'>Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety.</a> September 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15538050/'>Frequent activation of CArG binding factor-A expression and binding in N-methyl-N-nitrosourea-induced rat mammary carcinomas.</a> November 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15735660/'>Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.</a> March 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16081693/'>Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate.</a> August 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16360014/'>The kappa promoter penta-decamer binding protein CBF-A interacts specifically with nucleophosmin in the nucleus only.</a> December 20  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16598313/'>Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).</a> April 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17098936/'>Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.</a> November 14  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17515202/'>Construction of strong mammalian promoters by random cis-acting element elongation.</a> May 23  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17716999/'>The tetraplex (CGG)n destabilizing proteins hnRNP A2 and CBF-A enhance the in vivo translation of fragile X premutation mRNA.</a> August 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17960171/'>Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.</a> October 26  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18480411/'>In cultured oligodendrocytes the A/B-type hnRNP CBF-A accompanies MBP mRNA bound to mRNA trafficking sequences.</a> May 16  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18762718/'>Cloning and characterization of porcine CArG binding factor A expression in the anterior pituitary.</a> September 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19273535/'>The quadruplex r(CGG)n destabilizing cationic porphyrin TMPyP4 cooperates with hnRNPs to increase the translation efficiency of fragile X premutation mRNA.</a> June 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19468270/'>Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?</a> September 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19603346/'>Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome.</a> February 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20493910/'>Characterization of nuclear factors modulating the apolipoprotein D promoter during growth arrest: implication of PARP-1, APEX-1 and ERK1/2 catalytic activities.</a> October 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20608165/'>[Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].</a> September 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21275954/'>Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.</a> August 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21537931/'>Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects.</a> February 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23023762/'>Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.</a> July 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23321257/'>Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.</a> May 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23636907/'>Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia.</a> October 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23672350/'>BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML.</a> October 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23672313/'>Presence of C11orf95-MKL2 fusion is a consistent finding in chondroid lipomas: a study of eight cases.</a> December 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23672298/'>Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.</a> April 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23672290/'>Effects of serum reduction and VEGF supplementation on angiogenic potential of human adipose stromal cells in vitro.</a> July 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23783394/'>The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.</a> October 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25975190/'>Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.</a> April 14  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26111469/'>Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic Opportunities.</a> October 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26397705/'>Transcriptome Profiling of Pediatric Core Binding Factor AML.</a> June 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26980726/'>Comprehensive mutational profiling of core binding factor acute myeloid leukemia.</a> June 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27505005/'>Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.</a> August 10  2016<br></body></html>
